| 1 |
Aspirin FDA Label
|
| 2 |
Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90.
|
| 3 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4139).
|
| 4 |
Protective Effect of Aspirin on COVID-19 Patients (PEAC)
|
| 5 |
Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
|
| 6 |
ClinicalTrials.gov (NCT02384070) Simplified Anti-Thrombotic Therapy for FFR
|
| 7 |
ClinicalTrials.gov (NCT05960721) Low-dose NOAC Versus GDMT After LAAO
|
| 8 |
ClinicalTrials.gov (NCT01429272) Minocycline and Aspirin in the Treatment of Bipolar Depression
|
| 9 |
ClinicalTrials.gov (NCT03543683) Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC
|
| 10 |
ClinicalTrials.gov (NCT00963443) Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold
|
| 11 |
ClinicalTrials.gov (NCT00059306) Secondary Prevention of Small Subcortical Strokes Trial
|
| 12 |
ClinicalTrials.gov (NCT00983580) Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
|
| 13 |
ClinicalTrials.gov (NCT00335452) Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS
|
| 14 |
#N/A
|
| 15 |
ClinicalTrials.gov (NCT05994287) Pain Treatment With Combinations of NSAIDs
|
| 16 |
ClinicalTrials.gov (NCT00175838) Primary Thrombocythaemia 1 Trial
|
| 17 |
An overview of proton pump inhibitors. Gastroenterol Nurs. 2003 Sep-Oct;26(5):182-90.
|
| 18 |
ClinicalTrials.gov (NCT02229461) Naproxen Sodium/ASA Platelet Study
|
| 19 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 20 |
ClinicalTrials.gov (NCT05209412) Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions
|
| 21 |
ClinicalTrials.gov (NCT04971356) 1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon
|
| 22 |
ClinicalTrials.gov (NCT01744288) Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets
|
| 23 |
ClinicalTrials.gov (NCT00528411) A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin
|
| 24 |
ClinicalTrials.gov (NCT01409616) To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their Effects
|
| 25 |
ClinicalTrials.gov (NCT01424332) To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects
|
| 26 |
ClinicalTrials.gov (NCT00357682) A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
|
| 27 |
ClinicalTrials.gov (NCT01431053) Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer
|
| 28 |
ClinicalTrials.gov (NCT03128346) Analgesic Effects of Transversus Thoracic Plane (TTP) Block in Cardiac Surgery
|
| 29 |
ClinicalTrials.gov (NCT01965002) Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors
|
| 30 |
ClinicalTrials.gov (NCT05580523) Aspirin Versus Metformin in Pregnancies at High Risk of Preterm Preeclampsia: a 3-arm Randomized Controlled Trial
|
| 31 |
ClinicalTrials.gov (NCT01589978) PROMUS Element Plus US Post-Approval Study
|
| 32 |
ClinicalTrials.gov (NCT00719537) Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia
|
| 33 |
ClinicalTrials.gov (NCT01486433) The Effect of Multiple Doses of Epanova on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects
|
| 34 |
ClinicalTrials.gov (NCT00384865) A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension
|
| 35 |
ClinicalTrials.gov (NCT02419820) Dose-escalation, Repeated and Single Oral Dosing Study
|
| 36 |
ClinicalTrials.gov (NCT00684515) Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)
|
| 37 |
ClinicalTrials.gov (NCT03503227) The Value of Prednisolone With Aspirin Before Embryo Transfer in Intracytoplasmic Sperm Injection (ICSI) Cycles
|
| 38 |
ClinicalTrials.gov (NCT01976806) The Effects of DHA on Periodontitis
|
| 39 |
ClinicalTrials.gov (NCT02878772) Vinpocetine Inhibits NF-B-dependent Inflammation in Acute Ischemic Stroke Patients
|
| 40 |
ClinicalTrials.gov (NCT04160546) Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP)
|
| 41 |
ClinicalTrials.gov (NCT02348203) Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers
|
| 42 |
ClinicalTrials.gov (NCT02685748) Aspirin in Young Psychotic Patients
|
| 43 |
ClinicalTrials.gov (NCT04824911) Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease
|
| 44 |
ClinicalTrials.gov (NCT02081638) Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
|
| 45 |
ClinicalTrials.gov (NCT04534218) Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer
|
| 46 |
ClinicalTrials.gov (NCT01802775) Edoxaban in Peripheral Arterial Disease
|
| 47 |
ClinicalTrials.gov (NCT05122455) Effects of Edoxaban on Platelet Aggregation
|
| 48 |
ClinicalTrials.gov (NCT02183688) Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients
|
| 49 |
ClinicalTrials.gov (NCT02556203) Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes
|
| 50 |
ClinicalTrials.gov (NCT05265299) Trial to Determine Effective Aspirin Dose in COPD
|
| 51 |
ClinicalTrials.gov (NCT02294643) Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study
|
| 52 |
ClinicalTrials.gov (NCT04343001) Coronavirus Response - Active Support for Hospitalised Covid-19 Patients. U.S. National Institutes of Health.
|
| 53 |
ClinicalTrials.gov (NCT05476991) Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
|
| 54 |
ClinicalTrials.gov (NCT01936233) Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
|
| 55 |
ClinicalTrials.gov (NCT02833948) Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)
|
| 56 |
ClinicalTrials.gov (NCT03819101) Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
|
| 57 |
ClinicalTrials.gov (NCT01813435) GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
|
| 58 |
ClinicalTrials.gov (NCT01598337) The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency
|
| 59 |
ClinicalTrials.gov (NCT05573958) To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
|
| 60 |
ClinicalTrials.gov (NCT04990791) WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?
|
| 61 |
ClinicalTrials.gov (NCT02594410) Zainidip in Renal Artery Stenosis
|
| 62 |
ClinicalTrials.gov (NCT04949516) Mono Antiplatelet and Colchicine Therapy
|
| 63 |
ClinicalTrials.gov (NCT04006288) Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
| 64 |
ClinicalTrials.gov (NCT02786979) Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients
|
| 65 |
ClinicalTrials.gov (NCT05310968) Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction
|
| 66 |
ClinicalTrials.gov (NCT03807921) Anticoagulation for Aortic Bioprosthesis (ANTIPRO)
|
| 67 |
ClinicalTrials.gov (NCT02090413) Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis
|
| 68 |
ClinicalTrials.gov (NCT02757365) Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer
|
| 69 |
ClinicalTrials.gov (NCT02022527) Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis
|
| 70 |
ClinicalTrials.gov (NCT03224923) A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)
|
| 71 |
ClinicalTrials.gov (NCT02567461) Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel
|
| 72 |
ClinicalTrials.gov (NCT01917799) Aspirin, Heparin and Miscarriage
|
| 73 |
ClinicalTrials.gov (NCT02986594) Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla
|
| 74 |
ClinicalTrials.gov (NCT02548650) Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus
|
| 75 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
|
|
|
|
|
|
|
